WellSpring Pharmaceutical Corp. has expanded its consumer health care product line with the acquisition of several OTC products from McNeil Consumer Healthcare Division. In an all-cash transaction, WellSpring has purchased U.S. rights to Micatin (antifungal), Emetrol (anti-nausea), and Gelusil (antacid), and the Canadian rights to Micatin, Gelusil, and Glycerin Suppositories (laxative).       In the U.S. the new brands give WellSpring a base in the consumer healthcare market where the company...